Study on insulin therapy and colorectal cancer risk

As a common tumor disease, colorectal cancer has various causes. Bad habits in life and autoimmune health problems may increase the risk of colorectal cancer. Recent medical clinical studies have found that patients receiving insulin treatment have a high risk of colorectal cancer , which means that insulin indirectly leads to an increased incidence of colorectal cancer.

Studies have shown that patients with type 2 diabetes who receive long-term insulin treatment have a significantly higher risk of colorectal cancer than those who do not receive insulin treatment. Moreover, the longer the patient receives insulin treatment, the higher the risk of colorectal cancer - patients who receive insulin treatment for at least 3 years have a 3-fold risk of developing such cancer compared to those who do not receive insulin treatment; those who receive insulin treatment for no more than 5 years have a 4-fold higher risk of developing such cancer than those who do not receive insulin treatment.

The increased risk of colorectal cancer in long-term insulin users may be due to the use of insulin, the severity of the patient's disease, or both. Researchers suspect that insulin stimulates the growth of cancer cells. However, the above studies are not sufficient to confirm the relationship between insulin dependence and colorectal cancer.

Due to the limitations and incompleteness of the research, the relationship between insulin therapy and the risk of colorectal cancer can only be used as a reference. We hope that readers can consider this uncertain factor when preventing and diagnosing colorectal cancer. It will be beneficial rather than harmful to your health to make comprehensive preparations.

For more information, please visit the gastric cancer disease special topic at http://www..com.cn/zhongliu/ca/ or consult an expert for free. The expert will then give a detailed answer based on the patient's specific situation.